NCT03508167View on ClinicalTrials.gov

Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain.

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

November 30, 2020

Conditions
Low Back Pain
Interventions
DEVICE

Thermal Band

Thermal Band used 8 hours per day

DRUG

Dorilax®

"2 tablets, orally. In case of moderate pain, another 2 tablets could be administered, respecting the interval of 8 hours between the administrations.~Maximum dosage per day: 6 tablets."

DRUG

Placebo

"2 tablets, orally. In case of moderate pain, another 2 tablets could be administered, respecting the interval of 8 hours between the administrations.~Maximum dosage per day: 6 tablets."

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY

NCT03508167 - Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain. | Biotech Hunter | Biotech Hunter